Evidence map›Paper›PMID 37346792›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Micronutrient optimization for tissue engineered articular cartilage production of type II collagen.

Maria A Cruz, Yamilet Gonzalez, Javier A Vélez Toro, Makan Karimzadeh, Anthony Rubbo, Lauren Morris, Ramapaada Medam, Taylor Splawn, Marilyn Archer, Russell J Fernandes and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Maria A CruzBiionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
Yamilet GonzalezBiionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
Javier A Vélez ToroBiionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
Makan KarimzadehBiionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
Anthony RubboBiionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
Lauren MorrisBiionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
Ramapaada MedamBiionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
Taylor SplawnBaylor College of Medicine, Houston, TX, United States.
Marilyn ArcherDepartment of Orthopaedics and Sports Medicine, University of Washington, Seattle, WA, United States.
Russell J FernandesDepartment of Orthopaedics and Sports Medicine, University of Washington, Seattle, WA, United States.
James E DennisBaylor College of Medicine, Houston, TX, United States.
Thomas J KeanBiionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
Florida College · USUniversity of Central Florida · USBaylor College of Medicine · USUniversity of Washington · US

Funding

Collagen Assembly in Tissue-Engineered CartilageR01AR057025 · NIAMS · UNIVERSITY OF WASHINGTON · PI FERNANDES, RUSSELL J · 2010 to 2022
$2.9M
NIAMS NIH HHS R01 AR057025
6 · The paper itself

Abstract

Tissue Engineering of cartilage has been hampered by the inability of engineered tissue to express native levels of type II collagen

Indexed as

design of experiments (DoE)extracellular matrix reportermedia optimizationprimary chondrocytescaffold-free tissue engineered cartilagetissue engineered cartilagetype II collagen heteropolymervitamins and minerals

Identifiers

PMID37346792
PMCPMC10280293
OpenAlexW4379536472

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.